Torbjörn Gräslund

20PUBLICATIONS
44CO-AUTHORS
Molecular targetsPredictive and prognostic markersNanomaterialsMedical devicesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Nov 20, 2025
Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents.

Sara S Rinne, Wen Yin, Ruonan Li

|Jun 13, 2025
Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture.

Vladimir Tolmachev, Anzhelika Vorobyeva, Alia Hani Binti Rosly

|Oct 17, 2024
Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts.

Jie Zhang, Sara S Rinne, Wen Yin

|Oct 02, 2024
Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model.

Soraia Pinto, Juliana Viegas, Cecília Cristelo

|Apr 27, 2024
Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion.

Sergey M Deyev, Maryam Oroujeni, Javad Garousi

|Nov 11, 2022
Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with 99mTc for Radionuclide Imaging of HER2 Expression in Cancer.

Mariia Larkina, Evgenii Plotnikov, Ekaterina Bezverkhniaia

Pageof 4

Frequent Collaborators

15 joint publications

Anna Orlova

15 joint publications

Anzhelika Vorobyeva

13 joint publications

Vladimir Tolmachev

10 joint publications

Tianqi Xu